ARTICLE | Financial News
Arch Therapeutics completes direct public offering
February 24, 2017 7:02 PM UTC
On Feb. 21, hemostasis company Arch Therapeutics Inc. (OTCQB:ARTH) raised $6.1 million through the sale of 10.2 million units at $0.60 in a registered direct offering with six accredited investors. E...
BCIQ Company Profiles